Returns
-0.05%
Loading chart...
Fundamentals
Large Cap
Financial - Banking
Market Cap (Cr)
18062.01
Earning Per Share
-973.57
Dividend Yield
-%
P/E Ratio
-
P/B Ratio
43.60
Debt to Equity
1.21
Performance
min-value
max-value
Open
56,601.30
52-wk High
75,250.00
High
56,601.30
52-wk Low
75,250.00
Low
56,601.30
Band
75,250.00
Lower Circuit
56,601.30
Upper Circuit
75,250.00
Volume
56,601.30
VWAP
75,250.00
52 Week Performance
min-value
max-value

5.34% down side
up side5.34%

About the company
Onesource Specialty Pharma Limited was incorporated as a Private Limited Company, with the name and style of Inbiopro Solutions Private Limited' dated June 12, 2007, was issued by the Registrar of Companies, Karnataka at Bangalore. The Company name was then changed to Stelis Biopharma Private Limited', pursuant to a Scheme of Amalgamation and a Certificate of Incorporation dated December 24, 2014, was issued by the Registrar of Companies. The status of the Company was then converted from a Private Limited Company to a Public Limited Company, and renamed as Stelis Biopharma Limited' dated July 31, 2021,. Subsequently, the name was changed to its present Onesource Specialty Pharma Limited' on February 13, 2024, and a fresh Certificate of Incorporation dated February 13, 2024, was issued by the Registrar of Companies, Karnataka at Bangalore. A Scheme of Arrangement amongst Strides Pharma Science Limited, Steriscience Specialties Private Limited and the Company and their respective shareholders and creditors was implemented on November 14, 2024.